Skip to main content

Upadacitinib is a Double Edged Vascular Sword in GCA

Oct 26, 2025 11:41 pm

Dr. David Liew discusses abstracts O751, O738, and O734 presented at the 2025 ACR Convergence meeting in Chicago.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×